Net profit of Aurobindo Pharma declined 9.66% to Rs 845.81 crore in the quarter ended December 2024 as against Rs 936.29 crore during the previous quarter ended December 2023. Sales rose 8.55% to Rs 7893.15 crore in the quarter ended December 2024 as against Rs 7271.23 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 7893.15 | 7271.23 | 9 |
OPM % | 19.99 | 21.99 | - |
PBDT | 1618.38 | 1685.69 | -4 |
PBT | 1199.85 | 1262.42 | -5 |
NP | 845.81 | 936.29 | -10 |